Genomic Valley Biotech

Jhajjar, India Founded: 1994 • Age: 32 yrs
RD company focused on plant tissue cultured plants
Annual revenue $18,700 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors - Brand Intelligence

About Genomic Valley Biotech

Genomic Valley Biotech was founded in 1994 and is based in Jhajjar, India. Operations center on research and development within the biotechnology sector, specifically plant tissue culture techniques. Services include the production and propagation of tissue-cultured plants for agricultural and horticultural applications. The company is led by Managing Director and Chairman Yogesh Agrawal. Activities are conducted to support advancements in plant propagation and genetic stability.

  • Headquarter Jhajjar, India
  • Stage Public
  • Sectors
    Agriculture
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Legal Name Genomic Valley Biotech Ltd
Operational Areas
Agriculture → Agricultural Technology & Innovation
Key Metrics
  • Annual Revenue
    $18.7 K (USD)
    -26.74
    as on Mar 31, 2022
  • Net Profit
    -$1.13 K (USD)
    98.33
    as on Mar 31, 2022
  • EBITDA
    -$45.71 K (USD)
    -173.68
    as on Mar 31, 2022
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Genomic Valley Biotech

Genomic Valley Biotech is a publicly listed company on the BSE with ticker symbol GVBL in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: BSE · Ticker: GVBL · Sector: Health technology · India

Funding Insights of Genomic Valley Biotech

Investments & Acquisitions by Genomic Valley Biotech

Investments

Financial Statements - Genomic Valley Biotech

Genomic Valley Biotech Comparisons

+
Add Comparison
Available on Premium

Competitors of Genomic Valley Biotech

Latest news on Genomic Valley Biotech

Frequently Asked Questions about Genomic Valley Biotech

Genomic Valley Biotech was founded in 1994.

Genomic Valley Biotech is headquartered in Jhajjar, India. It is registered at Jhajjar, Haryana, India.

Annual revenue of Genomic Valley Biotech is $18.7K as on Mar 31, 2022.

Genomic Valley Biotech was founded in 1994 and is based in Jhajjar, India. Operations center on research and development within the biotechnology sector, specifically plant tissue culture techniques. Services include the production and propagation of tissue-cultured plants for agricultural and horticultural applications. The company is led by Managing Director and Chairman Yogesh Agrawal. Activities are conducted to support advancements in plant propagation and genetic stability.

Yes, Genomic Valley Biotech is publicly traded on BSE under the ticker symbol GVBL.

The ticker symbol of Genomic Valley Biotech is GVBL on BSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available